Related Experiment Video
Updated: Jun 28, 2026
05:56
Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting
Published on: June 21, 2024
Integrating complementary and alternative medicine education into the pharmacy curriculum
Evelin Tiralongo1, Marianne Wallis
1School of Pharmacy, Griffith University Gold Coast, Australia. E.Tiralongo@griffith.edu.au
American Journal of Pharmaceutical Education
|November 13, 2008
Summary
Integrating evidence-based complementary and alternative medicine (CAM) education throughout pharmacy school improved students' knowledge and resource use. Earlier integration, starting in the first year, was preferred by students.
Area of Science:
- Pharmacy Education
- Integrative Medicine
Background:
- Complementary and Alternative Medicine (CAM) is increasingly relevant in healthcare.
- Pharmacy curricula need to address evidence-based CAM to prepare future pharmacists.
Purpose of the Study:
- To assess the impact of integrating evidence-based CAM education into a pharmacy program.
- To evaluate student knowledge and resource utilization regarding CAM.
Main Methods:
- Evidence-based CAM content was woven into the third, fourth, and fifth years of a pharmacy curriculum.
- An introductory CAM module was introduced in the third year.
- CAM topics were integrated into clinical lectures and case studies in later years.
Main Results:
- Student knowledge of CAM and use of evidence-based CAM resources significantly increased.
- A majority of fourth-year students desired more comprehensive CAM education.
- Students favored earlier curriculum integration of CAM, ideally starting in year one.
Conclusions:
- A multi-year, integrated approach to teaching evidence-based CAM enhances pharmacy students' knowledge and application.
- Curriculum design should consider student preference for earlier and more extensive CAM education.
Related Concept Videos
01:19Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...
01:26Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
01:28Dosage Regimens: Designs and Approaches
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:28Biopharmaceutics and Pharmacokinetics: Overview
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the appropriate...